Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1976 May;57(1):133–140. doi: 10.1111/j.1476-5381.1976.tb07663.x

On the actions of compounds related to dopamine at a neurosecretory synapse.

B L Ginsborg, K W Turnbull, C R House
PMCID: PMC1667013  PMID: 1276532

Abstract

1 The effects of a number of substances related to dopamine, including all its methylated derivatives, were investigated on the membrane potential and response to nerve stimulation of cockroach salivary gland cells. 2 Only N-methyldopamine (epinine), N,N-dimethyldopamine and N,N-dimethylnoradrenaline, all with unsubstituted hydroxyl groups, directly resembled dopamine in producing a hyperpolarization which could be as large as that caused by maximal nerve stimulation. During the continued presence of these substances the hyperpolarization waned and responses to nerve stimulation declined. 3 Many of the compounds caused one or both of two other effects, namely an increase in the rate of 'spontaneous miniature hyperpolarizations' and an enhancement of the submaximal responses to single nerve stimuli. There were no obvious structural requirements for these effects.

Full text

PDF
133

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ascher P. Inhibitory and excitatory effects of dopamine on Aplysia neurones. J Physiol. 1972 Aug;225(1):173–209. doi: 10.1113/jphysiol.1972.sp009933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berry M. S., Cottrell G. A. Excitatory, inhibitory and biphasic synaptic potentials mediated by an identified dopamine-containing neurone. J Physiol. 1975 Jan;244(3):589–612. doi: 10.1113/jphysiol.1975.sp010814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Costall B., Naylor R. J., Pinder R. M. Design of agents for stimulation of neostriatal dopaminergic mechanisms. J Pharm Pharmacol. 1974 Oct;26(10):753–756. doi: 10.1111/j.2042-7158.1974.tb09170.x. [DOI] [PubMed] [Google Scholar]
  4. Ernst A. M. Relation between the structure of certain methoxyphenylethylaminederivatives and the occurrence of a hypokinetic rigid syndrome. Psychopharmacologia. 1965 May 21;7(6):383–390. doi: 10.1007/BF00402360. [DOI] [PubMed] [Google Scholar]
  5. FELLMAN J. H. Fluoroarterenol: a fluorine isostere of norepinephrine. Nature. 1957 Feb 2;179(4553):265–266. doi: 10.1038/179265a0. [DOI] [PubMed] [Google Scholar]
  6. Fry J. P., House C. R., Sharman D. F. Proceedings: An analysis of the catecholamine content of the salivary gland of the cockroach. Br J Pharmacol. 1974 May;51(1):116P–117P. [PMC free article] [PubMed] [Google Scholar]
  7. Ginsborg B. L., House C. R., Silinsky E. M. Conductance changes associated with the secretory potential in the cockroach salivary gland. J Physiol. 1974 Feb;236(3):723–731. doi: 10.1113/jphysiol.1974.sp010462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goldberg L. I. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev. 1972 Mar;24(1):1–29. [PubMed] [Google Scholar]
  9. Goldberg L. I., Sonneville P. F., McNay J. L. An investigation of the structural requirements for dopamine-like renal vasodilation: phenylethylamines and apomorphine. J Pharmacol Exp Ther. 1968 Sep;163(1):188–197. [PubMed] [Google Scholar]
  10. Hirst G. D., Silinsky E. M. Some effects of 5-hydroxytryptamine, dopamine and noradrenaline on neurones in the submucous plexus of guinea-pig small intestine. J Physiol. 1975 Oct;251(3):817–832. doi: 10.1113/jphysiol.1975.sp011124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev. 1966 Jun;18(2):925–964. [PubMed] [Google Scholar]
  12. Hornykiewicz O. Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). Br Med Bull. 1973 May;29(2):172–178. doi: 10.1093/oxfordjournals.bmb.a070990. [DOI] [PubMed] [Google Scholar]
  13. House C. R., Ginsborg B. L., Silinsky E. M. Dopamine receptors in cockroach salivary gland cells. Nat New Biol. 1973 Sep 12;245(141):63–63. doi: 10.1038/newbio245063a0. [DOI] [PubMed] [Google Scholar]
  14. Iversen L. L. Dopamine receptors in the brain. Science. 1975 Jun 13;188(4193):1084–1089. doi: 10.1126/science.2976. [DOI] [PubMed] [Google Scholar]
  15. Matthysse S., Lipinski J. Biochemical aspects of schizophrenia. Annu Rev Med. 1975;26:551–565. doi: 10.1146/annurev.me.26.020175.003003. [DOI] [PubMed] [Google Scholar]
  16. Miller R., Horn A., Iversen L., Pinder R. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography. Nature. 1974 Jul 19;250(463):238–241. doi: 10.1038/250238a0. [DOI] [PubMed] [Google Scholar]
  17. Silinsky E. M. The effects of bretylium and guanethidine on catecholaminergic transmission in an invertebrate. Br J Pharmacol. 1974 Jul;51(3):367–371. doi: 10.1111/j.1476-5381.1974.tb10671.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Snyder S. H., Banerjee S. P., Yamamura H. I., Greenberg D. Drugs, neurotransmitters, and schizophrenia. Science. 1974 Jun 21;184(4143):1243–1253. doi: 10.1126/science.184.4143.1243. [DOI] [PubMed] [Google Scholar]
  19. Vogt M. Functional aspects of the role of catecholamines in the central nervous system. Br Med Bull. 1973 May;29(2):168–172. doi: 10.1093/oxfordjournals.bmb.a070989. [DOI] [PubMed] [Google Scholar]
  20. Von Voigtlander P. F., Moore K. E. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine. J Pharmacol Exp Ther. 1973 Mar;184(3):542–552. [PubMed] [Google Scholar]
  21. Woodruff G. N. Dopamine receptors: a review. Comp Gen Pharmacol. 1971 Dec;2(8):439–455. doi: 10.1016/0010-4035(71)90041-3. [DOI] [PubMed] [Google Scholar]
  22. Woodruff G. N., Walker R. J. The effect of dopamine and other compounds on the activity of neurones of Helix aspersa; structure-activity relationships. Int J Neuropharmacol. 1969 May;8(3):279–289. doi: 10.1016/0028-3908(69)90049-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES